Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Korro Bio, Inc.
Korro Bio, Inc. News
Korro Bio, Inc. Quantitative Score
About Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Korro Bio, Inc. Earnings & Revenue
Korro Bio, Inc. Financials
Table Compare
Compare KRRO metrics with: | |||
|---|---|---|---|
Earnings & Growth | KRRO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | KRRO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | KRRO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | KRRO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Korro Bio, Inc. Income
Korro Bio, Inc. Balance Sheet
Korro Bio, Inc. Cash Flow
Korro Bio, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Korro Bio, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Korro Bio, Inc. Executives
| Name | Role |
|---|---|
| Dr. Ram Aiyar MBA, Ph.D. | Chief Executive Officer, President, Interim Principal Financial Officer & Director |
| Mr. Vineet Agarwal M.B.A. | Chief Financial Officer (Leave of Absence) |
| Mr. Nessan Bermingham Ph.D. | Co-Founder & Independent Chairman of the Board |
| Dr. Jean-Francois Formela M.D., MBA | Co-Founder & Independent Director |
| Dr. Joshua Rosenthal Ph.D. | Co-Founder & Advisor |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Ram Aiyar MBA, Ph.D. | Chief Executive Officer, President, Interim Principal Financial Officer & Director | 1979 | 844.87K | |
| Mr. Vineet Agarwal M.B.A. | Chief Financial Officer (Leave of Absence) | Male | 1983 | 811.77K |
| Mr. Nessan Bermingham Ph.D. | Co-Founder & Independent Chairman of the Board | Male | 1973 | 202.14K |
| Dr. Jean-Francois Formela M.D., MBA | Co-Founder & Independent Director | 1957 | 8.21K | |
| Dr. Joshua Rosenthal Ph.D. | Co-Founder & Advisor | -- |
Korro Bio, Inc. Insider Trades
| Date | 11 Feb |
| Name | Dolan Oliver |
| Role | Senior Vice President, Finance |
| Transaction | Disposed |
| Type | |
| Shares | 15000 |
| Date | 11 Feb |
| Name | Dolan Oliver |
| Role | Senior Vice President, Finance |
| Transaction | Disposed |
| Type | |
| Shares | 6000 |
| Date | 3 Feb |
| Name | Cerio Jeffrey |
| Role | General Counsel |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 29000 |
| Date | 3 Feb |
| Name | Agarwal Vineet |
| Role | Chief Financial Officer |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 30000 |
| Date | 3 Feb |
| Name | Aiyar Ram |
| Role | President and CEO |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 100000 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 11 Feb | Dolan Oliver | Senior Vice President, Finance | Disposed | 15000 | |
| 11 Feb | Dolan Oliver | Senior Vice President, Finance | Disposed | 6000 | |
| 3 Feb | Cerio Jeffrey | General Counsel | Acquired | A-Award | 29000 |
| 3 Feb | Agarwal Vineet | Chief Financial Officer | Acquired | A-Award | 30000 |
| 3 Feb | Aiyar Ram | President and CEO | Acquired | A-Award | 100000 |